1
|
Erokhov PA, Kulikov AM, Karpova YD, Rodoman GV, Sumedi IR, Goncharov AL, Razbirin DV, Gorelova VS, Sharova NP, Astakhova TM. Proteasomes in Patient Rectal Cancer and Different Intestine Locations: Where Does Proteasome Pool Change? Cancers (Basel) 2021; 13:1108. [PMID: 33807574 PMCID: PMC7961961 DOI: 10.3390/cancers13051108] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2021] [Accepted: 03/01/2021] [Indexed: 01/12/2023] Open
Abstract
A special problem in the surgery of rectal cancer is connected with a need for appropriate removal of intestine parts, along with the tumor, including the fragment close to the sphincter. To determine the length of fragments to remove, it is necessary to reveal areas without changes in molecule functioning, specific for tumor. The purpose of the present study was to investigate functioning the proteasomes, the main actors in protein hydrolysis, in patient rectal adenocarcinoma and different intestine locations. Chymotrypsin-like and caspase-like activities, open to complex influence of different factors, were analyzed in 43-54 samples by Suc-LLVY-AMC- and Z-LLE-AMC-hydrolysis correspondingly. Both activities may be arranged by the decrease in the location row: cancer→adjacent tissue→proximal (8-20 cm from tumor) and distal (2 and 4 cm from tumor) sides. These activities did not differ noticeably in proximal and distal locations. Similar patterns were detected for the activities and expression of immune subunits LMP2 and LMP7 and expression of 19S and PA28αβ activators. The largest changes in tumor were related to proteasome subtype containing LMP2 and PA28αβ that was demonstrated by native electrophoresis. Thus, the results indicate a significance of subtype LMP2-PA28αβ for tumor and absence of changes in proteasome pool in distal fragments of 2-4 cm from tumor.
Collapse
Affiliation(s)
- Pavel A. Erokhov
- Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia; (P.A.E.); (A.M.K.); (Y.D.K.); (V.S.G.); (T.M.A.)
| | - Alexey M. Kulikov
- Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia; (P.A.E.); (A.M.K.); (Y.D.K.); (V.S.G.); (T.M.A.)
| | - Yaroslava D. Karpova
- Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia; (P.A.E.); (A.M.K.); (Y.D.K.); (V.S.G.); (T.M.A.)
| | - Grigory V. Rodoman
- Pirogov Russian National Research Medical University of Ministry of Health of Russian Federation, 1 Ostrovityanov Street, 117997 Moscow, Russia; (G.V.R.); (I.R.S.); (A.L.G.); (D.V.R.)
| | - Ilia R. Sumedi
- Pirogov Russian National Research Medical University of Ministry of Health of Russian Federation, 1 Ostrovityanov Street, 117997 Moscow, Russia; (G.V.R.); (I.R.S.); (A.L.G.); (D.V.R.)
| | - Artem L. Goncharov
- Pirogov Russian National Research Medical University of Ministry of Health of Russian Federation, 1 Ostrovityanov Street, 117997 Moscow, Russia; (G.V.R.); (I.R.S.); (A.L.G.); (D.V.R.)
| | - Dmitry V. Razbirin
- Pirogov Russian National Research Medical University of Ministry of Health of Russian Federation, 1 Ostrovityanov Street, 117997 Moscow, Russia; (G.V.R.); (I.R.S.); (A.L.G.); (D.V.R.)
| | - Vera S. Gorelova
- Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia; (P.A.E.); (A.M.K.); (Y.D.K.); (V.S.G.); (T.M.A.)
| | - Natalia P. Sharova
- Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia; (P.A.E.); (A.M.K.); (Y.D.K.); (V.S.G.); (T.M.A.)
| | - Tatiana M. Astakhova
- Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia; (P.A.E.); (A.M.K.); (Y.D.K.); (V.S.G.); (T.M.A.)
| |
Collapse
|
2
|
Astakhova TM, Morozov AV, Erokhov PA, Mikhailovskaya MI, Akopov SB, Chupikova NI, Safarov RR, Sharova NP. Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial. Cancers (Basel) 2018; 10:E351. [PMID: 30257462 PMCID: PMC6209890 DOI: 10.3390/cancers10100351] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2018] [Revised: 09/12/2018] [Accepted: 09/22/2018] [Indexed: 11/16/2022] Open
Abstract
Tumor growth is associated with elevated proteasome expression and activity. This makes proteasomes a promising target for antitumor drugs. Current antitumor drugs such as bortezomib that inhibit proteasome activity have significant side effects. The purpose of the present study was to develop effective low-toxic antitumor compositions with combined effects on proteasomes. For compositions, we used bortezomib in amounts four and ten times lower than its clinical dose, and chose menadione sodium bisulfite (MSB) as the second component. MSB is known to promote oxidation of NADH, generate superoxide radicals, and as a result damage proteasome function in cells that ensure the relevance of MSB use for the composition development. The proteasome pool was investigated by the original native gel electrophoresis method, proteasome chymotrypsin-like activity-by Suc-LLVY-AMC-hydrolysis. For the compositions, we detected 10 and 20 μM MSB doses showing stronger proteasome-suppressing and cytotoxic in cellulo effects on malignant cells than on normal ones. MSB indirectly suppressed 26S-proteasome activity in cellulo, but not in vitro. At the same time, MSB together with bortezomib displayed synergetic action on the activity of all proteasome forms in vitro as well as synergetic antitumor effects in cellulo. These findings determine the properties of the developed compositions in vivo: antitumor efficiency, higher (against hepatocellular carcinoma and mammary adenocarcinoma) or comparable to bortezomib (against Lewis lung carcinoma), and drastically reduced toxicity (LD50) relative to bortezomib. Thus, the developed compositions represent a novel generation of bortezomib-based anticancer drugs combining high efficiency, low general toxicity, and a potentially expanded range of target tumors.
Collapse
Affiliation(s)
- Tatiana M Astakhova
- Laboratory of Biochemistry of Ontogenesis Processes, Koltzov Institute of Developmental Biology, Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia.
| | - Alexey V Morozov
- Laboratory of Regulation of Intracellular Proteolysis, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilov Street, 119991 Moscow, Russia.
| | - Pavel A Erokhov
- Laboratory of Biochemistry of Ontogenesis Processes, Koltzov Institute of Developmental Biology, Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia.
| | - Maria I Mikhailovskaya
- Laboratory of Biochemistry of Ontogenesis Processes, Koltzov Institute of Developmental Biology, Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia.
| | - Sergey B Akopov
- Laboratory of Human Genes Structure and Functions, Shemyakin⁻Ovchinnikov Institute of Bioorganic Chemistry of Russian Academy of Sciences, 16/10 Miklukho-Maklay Street, 117997 Moscow, Russia.
| | - Natalia I Chupikova
- Laboratory of Biochemistry of Ontogenesis Processes, Koltzov Institute of Developmental Biology, Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia.
| | - Ruslan R Safarov
- Laboratory of Biochemistry of Ontogenesis Processes, Koltzov Institute of Developmental Biology, Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia.
| | - Natalia P Sharova
- Laboratory of Biochemistry of Ontogenesis Processes, Koltzov Institute of Developmental Biology, Russian Academy of Sciences, 26 Vavilov Street, 119334 Moscow, Russia.
| |
Collapse
|
3
|
Mel’nikova VI, Khegai II, Popova NA, Lifantseva NV, Ivanova LN, Zakharova LA. Features of the immune proteasome expression in ascite Zajdela hepatoma after implantation into Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2014. [DOI: 10.1134/s1068162014060107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
4
|
Shashova EE, Lyupina YV, Glushchenko SA, Slonimskaya EM, Savenkova OV, Kulikov AM, Gornostaev NG, Kondakova IV, Sharova NP. Proteasome functioning in breast cancer: connection with clinical-pathological factors. PLoS One 2014; 9:e109933. [PMID: 25329802 PMCID: PMC4201529 DOI: 10.1371/journal.pone.0109933] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2014] [Accepted: 08/12/2014] [Indexed: 01/25/2023] Open
Abstract
Breast cancer is one of four oncology diseases that are most widespread in the world. Moreover, breast cancer is one of leading causes of cancer-related deaths in female population within economically developed regions of the world. So far, detection of new mechanisms of breast cancer development is very important for discovery of novel areas in which therapy approaches may be elaborated. The objective of the present study is to investigate involvement of proteasomes, which cleave up to 90% of cellular proteins and regulate numerous cellular processes, in mechanisms of breast cancer development. Proteasome characteristics in 106 patient breast carcinomas and adjacent tissues, as well as relationships of detected proteasome parameters with clinical-pathological factors, were investigated. Proteasome chymotrypsin-like activity was evaluated by hydrolysis of fluorogenic peptide Suc-LLVY-AMC. The expression of proteasome subunits was studied by Western-blotting and immunohistochemistry. The wide range of chymotrypsin-like activity in tumors was detected. Activity in tumors was higher if compared to adjacent tissues in 76 from 106 patients. Multiple analysis of generalized linear models discovered that in estrogen α-receptor absence, tumor growth was connected with the enhanced expression of proteasome immune subunit LMP2 and proteasome activator PA700 in tumor (at 95% confidence interval). Besides, by this analysis we detected some phenomena in adjacent tissue, which are important for tumor growth and progression of lymph node metastasis in estrogen α-receptor absence. These phenomena are related to the enhanced expression of activator PA700 and immune subunit LMP7. Thus, breast cancer development is connected with functioning of immune proteasome forms and activator PA700 in patients without estrogen α-receptors in tumor cells. These results could indicate a field for search of new therapy approaches for this category of patients, which has the worst prognosis of health recovery.
Collapse
Affiliation(s)
- Elena E. Shashova
- Department of Experimental Oncology, Cancer Research Institute of Siberian Branch of Russian Academy of Medical Sciences, Tomsk, Russia
| | - Yulia V. Lyupina
- Department of Biochemistry of Ontogenesis Processes, NK Koltsov Institute of Developmental Biology of Russian Academy of Sciences, Moscow, Russia
| | - Svetlana A. Glushchenko
- Department of Pathological Anatomy and Cytology, Cancer Research Institute of Siberian Branch of Russian Academy of Medical Sciences, Tomsk, Russia
| | - Elena M. Slonimskaya
- Department of General Oncology, Cancer Research Institute of Siberian Branch of Russian Academy of Medical Sciences, Tomsk, Russia
- Department of Oncology, Siberian State Medical University, Tomsk, Russia
| | - Olga V. Savenkova
- Department of Pathological Anatomy and Cytology, Cancer Research Institute of Siberian Branch of Russian Academy of Medical Sciences, Tomsk, Russia
| | - Alexey M. Kulikov
- Department of Evolutionary and Developmental Genetics, NK Koltsov Institute of Developmental Biology of Russian Academy of Sciences, Moscow, Russia
| | - Nikolay G. Gornostaev
- Department of Evolutionary and Developmental Genetics, NK Koltsov Institute of Developmental Biology of Russian Academy of Sciences, Moscow, Russia
| | - Irina V. Kondakova
- Department of Experimental Oncology, Cancer Research Institute of Siberian Branch of Russian Academy of Medical Sciences, Tomsk, Russia
| | - Natalia P. Sharova
- Department of Biochemistry of Ontogenesis Processes, NK Koltsov Institute of Developmental Biology of Russian Academy of Sciences, Moscow, Russia
| |
Collapse
|
5
|
Melnikova VI, Zakharova LA, Khegai II, Ivanova LN. Pattern RT1A and proteasome expression in cellular fractions of Zajdela ascitic hepatoma. DOKL BIOCHEM BIOPHYS 2014; 457:152-4. [PMID: 25172339 DOI: 10.1134/s1607672914040115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2014] [Indexed: 11/22/2022]
Affiliation(s)
- V I Melnikova
- Koltzov Institute of Developmental Biology, Russian Academy of Sciences, ul. Vavilova 26, Moscow, 119334, Russia,
| | | | | | | |
Collapse
|
6
|
Khegai II, Mel'nikova VI, Popova NA, Zakharova LA, Ivanova LN. The effect of vasopressin on the Zajdela hepatocellular carcinoma growth rate. DOKLADY BIOLOGICAL SCIENCES : PROCEEDINGS OF THE ACADEMY OF SCIENCES OF THE USSR, BIOLOGICAL SCIENCES SECTIONS 2014; 457:222-224. [PMID: 25172586 DOI: 10.1134/s0012496614040061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/25/2014] [Indexed: 06/03/2023]
Affiliation(s)
- I I Khegai
- Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia,
| | | | | | | | | |
Collapse
|
7
|
Sharova NP, Sumedi IR, Astakhova TM, Plekhanova AS, Lyupina YV, Shashova EE, Kondakova IV, Rodoman GV. Diagnostics of thyroid cancer: Limitations of the existing methods and perspectives for future developments. BIOL BULL+ 2014. [DOI: 10.1134/s1062359014040104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
8
|
Kondakova IV, Spirina LV, Koval VD, Shashova EE, Choinzonov EL, Ivanova EV, Kolomiets LA, Chernyshova AL, Slonimskaya EM, Usynin EA, Afanas’ev SG. Chymotrypsin-like activity and subunit composition of proteasomes in human cancers. Mol Biol 2014. [DOI: 10.1134/s002689331403011x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
9
|
Ivanova LN, Babina AV, Baturina GS, Katkova LE. Effect of vasopressin on the expression of genes for key enzymes of hyaluronan turnover in Wistar Albino Glaxo and Brattleboro rat kidneys. Exp Physiol 2013; 98:1608-19. [PMID: 23955305 DOI: 10.1113/expphysiol.2013.073163] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Lyudmila N Ivanova
- L. N. Ivanova: Institute of Cytology and Genetics Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia.
| | | | | | | |
Collapse
|